Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-24-132464·Foresite Capital Fund VI LP
Schedule 13G ownership disclosure
RAPT THERAPEUTICS INC
Common Stock · CUSIP: 75382E109
Event date: 2024-12-23
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Foresite Capital Fund VI, L.P.
Shares: 12,500,000.00 · Class: 9.3%
- Foresite Capital Management VI, LLC
Shares: 12,500,000.00 · Class: 9.3%
- James Tananbaum
Shares: 12,500,000.00 · Class: 9.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-132464
- Form type
- SCHEDULE 13G
- Filer
- Foresite Capital Fund VI LP
- CIK
- CIK 1932516
- Filed
- Dec 30, 2024
- Reporting period
- Dec 23, 2024
- Description
- Schedule 13G beneficial ownership